- CLL Prognostication/Risk Stratification Gene Panel (1)
- CLL Prognostication/Risk Stratification Gene Panel
The CLL Prognostication/Risk Stratification Gene Panel is a specialized genetic test used in the management and treatment of Chronic Lymphocytic Leukemia (CLL). CLL is a type of cancer that affects certain white blood cells called lymphocytes. This gene panel is designed to identify specific genetic mutations and chromosomal abnormalities in CLL cells that can help predict the prognosis and guide treatment decisions for individuals with CLL.
The gene panel typically includes the analysis of specific genes and genetic markers associated with CLL.
By analyzing the genetic makeup of CLL cells through this gene panel, healthcare providers can gain valuable information about the aggressiveness of the disease, the likelihood of treatment response, and potential treatment options tailored to the individual’s specific genetic profile.